Competitive Product

Competitive Product. In a given country, (i) a drug or biologic approved for marketing or in Phase 3 clinical development, (ii) a 510(k), or foreign equivalent, device approved for marketing, or (iii) a PMA, or foreign equivalent, device approved for marketing or in pivotal study clinical development, other than an Eligible Product, that acts (or is being developed to act) for one or more target label indications substantially similar to one or more approved or target label indications for an Eligible Product

Competitive Product. Means any pharmaceutical product (other than the Product itself) that has received final regulatory approval (including marketing, pricing, reimbursement and any other applicable approval) from the applicable Governmental Authority in a country in the Territory for use solely for the treatment of heart failure as an adjunct to current standard therapy in self-identified black patients to improve survival.

Competitive Product. Means any product that is administered nasally for the indication of allergic rhinitis regardless of the active Ingredient but not including the Amphotericin Product.

Competitive Product. Means any *** which is not ***.

Competitive Product. A product, either for prescription or over-the-counter sale, that is intended for use in a comparable indication, contains the same or substantially equivalent active ingredients or is otherwise competitive with the Product

Competitive Product. Any prescription drug that is listed as pharmaceutically equivalent to the Branded Product as listed in the FDA Orange Book, other than the Product sold pursuant to this Agreement

Competitive Product. (a) any device or analyzer that performs substantially similar functions as an Instrument and (b) any test, including rapid or lateral flow, that provides substantially similar test results or parameters as the Product.